Joel Greenblatt’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Joel Greenblatt's BEAM Position: Q3 2026 in Review
Joel Greenblatt sold out of Beam Therapeutics (BEAM) in Q3 2026, closing a stake of 10,720 shares — an estimated $368K sold.
Joel Greenblatt first reported a position in BEAM in Q1 2024 and held it in 2 quarters. The position peaked at $493K in Q1 2024. 261 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Joel Greenblatt reported no remaining Beam Therapeutics position as of Q3 2026 after selling out during the quarter.
- Joel Greenblatt sold 10,720 Beam Therapeutics shares in Q3 2026, an estimated $368K.
- Joel Greenblatt first reported a position in Beam Therapeutics in Q1 2024 and held it in 2 quarters.
- Joel Greenblatt's Beam Therapeutics position peaked at $493K in Q1 2024.
- 261 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.